HU188123B - Process for preparing new substituted imidazole derivatives and acid addition salts thereof - Google Patents

Process for preparing new substituted imidazole derivatives and acid addition salts thereof Download PDF

Info

Publication number
HU188123B
HU188123B HU80410A HU41080A HU188123B HU 188123 B HU188123 B HU 188123B HU 80410 A HU80410 A HU 80410A HU 41080 A HU41080 A HU 41080A HU 188123 B HU188123 B HU 188123B
Authority
HU
Hungary
Prior art keywords
bicyclo
imidazole
heteroatoms
preparation
formula
Prior art date
Application number
HU80410A
Other languages
English (en)
Hungarian (hu)
Inventor
Brian P Thorogood
Original Assignee
The Wellcome Foundation Ltd,Gb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Ltd,Gb filed Critical The Wellcome Foundation Ltd,Gb
Publication of HU188123B publication Critical patent/HU188123B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU80410A 1979-02-22 1980-02-21 Process for preparing new substituted imidazole derivatives and acid addition salts thereof HU188123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7906243 1979-02-22

Publications (1)

Publication Number Publication Date
HU188123B true HU188123B (en) 1986-03-28

Family

ID=10503360

Family Applications (1)

Application Number Title Priority Date Filing Date
HU80410A HU188123B (en) 1979-02-22 1980-02-21 Process for preparing new substituted imidazole derivatives and acid addition salts thereof

Country Status (20)

Country Link
US (2) US4328234A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0015002B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55115872A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR850000380B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT373881B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU531899B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3067505D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK75680A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8103055A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI800519A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2044259B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR70277B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU188123B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE49744B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL59444A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1128095B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MC (1) MC1315A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ192941A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT70856B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA80996B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188123B (en) * 1979-02-22 1986-03-28 The Wellcome Foundation Ltd,Gb Process for preparing new substituted imidazole derivatives and acid addition salts thereof
DE2944662A1 (de) * 1979-11-06 1981-05-14 Bayer Ag, 5090 Leverkusen Cycloheptatrienylimidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2944663A1 (de) * 1979-11-06 1981-05-14 Bayer Ag, 5090 Leverkusen Imidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS6036427B2 (ja) * 1980-12-05 1985-08-20 塩野義製薬株式会社 １−ベンジルイミダゾ−ル誘導体
DE3465993D1 (en) * 1983-08-11 1987-10-15 Synthelabo Indole derivatives, their preparation and their therapeutical application
DE3508905A1 (de) * 1985-03-13 1986-09-18 Hoechst Ag, 6230 Frankfurt Neue imidazolylverbindungen und verfahren zu ihrer herstellung
US4783474A (en) * 1985-07-20 1988-11-08 Bayer Aktiengesellschaft Halogenoalkyl-, alkenyl- and alkinyl-azoles
DE3700916A1 (de) * 1987-01-14 1988-07-28 Bayer Ag Halogenalkyl-, alkenyl- und alkinyl-azole
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
DE3827117A1 (de) * 1988-08-10 1990-02-15 Ruetgerswerke Ag Verfahren zur herstellung von chinuclidin-3-methanol
IT1251431B (it) * 1991-10-25 1995-05-09 Costante Fontana Composto ad elevate caratteristiche stabilizzanti particolarmente per perossidi inorganici utilizzati in applicazioni industriali
DE69637097T2 (de) * 1995-10-13 2007-09-20 Neurosearch A/S 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung
WO2006105217A2 (en) * 2005-03-31 2006-10-05 Schering Corporation Spirocyclic thrombin receptor antagonists

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836598A (en) * 1958-05-27 Tertiary-amino - substituted i
US29935A (en) * 1860-09-04 Joseph f
US3259637A (en) * 1963-05-27 1966-07-05 Frosst & Co Charles E 3, 3-dimethyl-8-bromomethyl-2, 7-dioxaspiro (4.4)nonane
GB1164564A (en) 1967-08-21 1969-09-17 Shell Int Research Novel Cyclobexylpentadienone Acid Derivatives, the preparation thereof and Compositions containing the same
USRE29935E (en) * 1968-11-29 1979-03-13 Bayer Aktiengesellschaft N-Substituted imidazoles and their salts
DE2007794A1 (de) * 1970-02-20 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Fungizide Mittel
US3666755A (en) * 1970-03-26 1972-05-30 Merck & Co Inc 2-imidazolylbicyclo{8 2.2.2{9 octanes
DE2016839C3 (de) * 1970-04-09 1979-03-22 Bayer Ag, 5090 Leverkusen PhenyM4-phenoxyphenyi)-imidazol-1-yl-methane, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US3682951A (en) * 1970-11-02 1972-08-08 Searle & Co 1-{8 {62 -(1-adamantyloxy)halophenethyl{9 {0 imidazoles and congeners
FR2129838A1 (en) * 1971-03-16 1972-11-03 Boehringer Mannheim Gmbh Diuretic/saluretic dibenzo cycloheptene - derivs
US4107206A (en) * 1974-04-08 1978-08-15 Akzona Incorporated Benzo-bicyclononene- derivatives
SE7600674L (sv) * 1975-02-05 1976-08-06 Rohm & Haas Fungicider
US4057549A (en) * 1975-04-16 1977-11-08 G. D. Searle & Co. Triarylpropyl-azabicyclooctanes
US4156694A (en) * 1975-04-29 1979-05-29 Akzona Incorporated Benzobicyclononene derivatives
US4036975A (en) * 1975-07-28 1977-07-19 Xyntex (U.S.A) Inc. 1-[2-(1-Adamantyl)-2-(R-thio)ethyl]imidazoles and 1-[2-(1-adamantyl)-2-(R-oxy)ethyl]imidazoles
US4031224A (en) * 1976-04-29 1977-06-21 American Hoechst Corporation 1,3-Dihydro-heteroarylspiro (isobenzofuran)s
US4396771A (en) * 1977-10-19 1983-08-02 Burroughs Wellcome Co. Imidazole derivatives and salts thereof
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
HU188123B (en) * 1979-02-22 1986-03-28 The Wellcome Foundation Ltd,Gb Process for preparing new substituted imidazole derivatives and acid addition salts thereof

Also Published As

Publication number Publication date
AT373881B (de) 1984-02-27
US4525475A (en) 1985-06-25
DK75680A (da) 1980-08-23
IT8047968A0 (it) 1980-02-21
KR850000380B1 (ko) 1985-03-23
ATA97580A (de) 1983-07-15
IT1128095B (it) 1986-05-28
IE800341L (en) 1980-08-22
ZA80996B (en) 1981-04-29
EP0015002A1 (en) 1980-09-03
FI800519A7 (fi) 1981-01-01
IE49744B1 (en) 1985-12-11
KR830001904A (ko) 1983-05-19
GR70277B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-09-03
GB2044259A (en) 1980-10-15
ES488803A0 (es) 1981-02-16
ES8103055A1 (es) 1981-02-16
EP0015002B1 (en) 1984-04-18
PT70856A (en) 1980-03-01
MC1315A1 (fr) 1981-03-10
NZ192941A (en) 1984-10-19
AU531899B2 (en) 1983-09-08
PT70856B (en) 1981-06-11
AU5576580A (en) 1980-08-28
US4328234A (en) 1982-05-04
GB2044259B (en) 1983-08-03
JPS55115872A (en) 1980-09-06
IL59444A0 (en) 1980-05-30
DE3067505D1 (en) 1984-05-24

Similar Documents

Publication Publication Date Title
US4528195A (en) Imidazole derivatives and salts thereof, their synthesis and intermediates and pharmaceutical formulations
US4829065A (en) Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
Walker et al. 1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents
HU188123B (en) Process for preparing new substituted imidazole derivatives and acid addition salts thereof
US4066692A (en) 11,12-secoprostaglandins
CA1266271A (en) 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists
US4837333A (en) Substituted alkylidene imidazoles
US4097504A (en) 11,12-Secoprostaglandins
US5091428A (en) Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
EP0420570A2 (en) Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis
WO1995003302A1 (en) Quinolizidines with calcium channel antagonistic activity
DE3874394T2 (de) 1,3-dioxane.
JPS6233227B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4935417A (en) Sustituted imidazolyl-alkyl-piperazine and -diazepine derivatives for treating cerebrovascular disease
US4908380A (en) Pharmaceutical compositions
US5010075A (en) Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
JPS6212773A (ja) ヘキセン酸、その製造法及びこれを含有する製薬組成物
US4775684A (en) 1,3-dioxane ethers
US4925869A (en) Therapeutic agents
FI90866B (fi) Menetelmä lääkeaineina käyttökelpoisten 4-/2-(imidatsol-1-yyli)etyylitio/bentsoehappojohdannaisten valmistamiseksi
FI81573C (fi) Foerfarande foer framstaellning av farmakologiskt verksamma 2-azolylmetyl-3-difluorbensyloxi-2,3-dihydro- fluorbenso/b/tiofener.
US5252736A (en) Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
JPH0819061B2 (ja) アミノアルコ−ル類
PT86890B (pt) Processo para a preparacao de 1-(1-aril-2-hidroxi-etil-)-imidazois e dos seus sais e de composicoes farmaceuticas que os contem
JPH0560462B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)